Rankings
Pricing
Log In
Free Trial
US-listed companies
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc.
ORIC
Market cap
$608.79M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Net loss
-74
-79
-89
Depreciation
1
1
1
Stock-based compensation expense
5
13
14
Loss on fixed asset disposals
-
-0
-0
(Accretion of discount) amortization of premium on investments, net
-0
-1
1
Prepaid expenses and other assets
2
-1
-1
Accounts payable and accrued other liabilities
4
3
-1
Net cash used in operating activities
-45
-60
-75
Acquisitions of property and equipment
1
1
2
Purchases of investments
225
70
238
Sales and maturities of investments
10
229
131
Net cash used in investing activities
-216
158
-109
Proceeds from issuance of common stock
133
50
25
Issuance costs associated with financings
-
2
0
Proceeds from issuance of common stock under the Employee Stock Purchase Plan
-
-
1
Proceeds from stock option exercises
0
1
0
Net cash provided by financing activities
251
49
25
Net (decrease) increase in cash and cash equivalents
-11
148
-159